Actively Recruiting
Surgery for Locally Unresectable Pancreatic Cancer
Led by Azienda Ospedaliera di Padova · Updated on 2025-11-26
150
Participants Needed
1
Research Sites
208 weeks
Total Duration
On this page
Sponsors
A
Azienda Ospedaliera di Padova
Lead Sponsor
U
University of Padova
Collaborating Sponsor
AI-Summary
What this Trial Is About
Pancreatic cancer is a severe disease often diagnosed at an advanced stage, when surgery is not possible. New chemotherapy treatments can sometimes shrink the tumor and make surgery an option. This study aims to understand if surgery after such treatments can improve survival and quality of life in selected patients treated at expert centers.
CONDITIONS
Official Title
Surgery for Locally Unresectable Pancreatic Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients older than 18 years
- Able to give informed consent
- Histologically confirmed pancreatic adenocarcinoma
- Locally advanced pancreatic cancer stage according to NCCN at diagnosis
- Received at least 4 months of induction chemotherapy
- Stable disease or partial response after induction therapy according to RECIST 1.1
- Considered eligible for radical resection by local multidisciplinary team
You will not qualify if you...
- Withdrawal of informed consent
- Tumor characteristics that prevent surgery
- Significant patient comorbidities that prevent surgery
- No available abdominal imaging before induction therapy
- Pathological confirmation of a tumor other than pancreatic ductal adenocarcinoma
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
UOC Chirurgia Generale 2, Azienda Ospedale di Padova, Padova, Italy 35128
Padova, Italy
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here